We are currently restructuring our databases, so be advised that the FCPAC database is updated only through July 30, 2025.

Processing your request


please wait...

 | Investigations Dataset

Stanford Foreign Corrupt Practices Act Clearinghouse a Collaboration with Sullivan & Cromwell LLP

Investigations Dataset

 
Investigation into Baxter's Activities in Unspecified Countries · Baxter International Inc.

Information & Summary

Investigation into Baxter's Activities in Unspecified Countries

Related FCPA Matter:   Baxter International's Involvement in Multiple Countries Information

Information & Summary

Investigation Name:    Investigation into Baxter's Activities in Unspecified Countries

Trend:    None

Type of investigation:    SEC, DOJ

Other Agencies Investigating/Assisting with SEC/DOJ Investigation:    Unknown

Whistleblower:    Unknown

Summary

Baxter International Inc. (Baxter) is an American multinational health care company with headquarters in Illinois. The company primarily focuses on products to treat hemophilia, kidney disease, immune disorders and other chronic and acute medical conditions. It is listed on the NYSE.

As disclosed in its November 3, 2010 10-Q, Baxter received an inquiry from the DOJ and SEC requesting the company to voluntarily provide information about business activities in a number of countries. The request was part of a broader review of industry practices for compliance with the U.S. Foreign Corrupt Practices Act. Baxter cooperated with the agencies, and in its February 21, 2014 10-K filing, disclosed that it was notified by both the DOJ and SEC that their respective investigations were closed without any further action taken.

Protected Content


Please Log In or Sign Up for a free account to access restricted features of the Clearinghouse website, including the Advanced Search form and the full case pages.

When you sign up, you will have the option to save your search queries performed on the Advanced Search form.